gsk peptide has been researched along with cyclin d1 in 1 studies
| Studies (gsk peptide) | Trials (gsk peptide) | Recent Studies (post-2010) (gsk peptide) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 7 | 1 | 1 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, DP; Doucas, H; Garcea, G; Manson, MM; Neal, CP | 1 |
1 review(s) available for gsk peptide and cyclin d1
| Article | Year |
|---|---|
Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance.
Topics: Axin Protein; beta Catenin; Carcinoma, Hepatocellular; Cyclin D1; Cytoskeletal Proteins; DNA-Binding Proteins; Frizzled Receptors; Gastrointestinal Neoplasms; Genes, APC; Genes, myc; Humans; Intercellular Signaling Peptides and Proteins; Liver Neoplasms; Matrix Metalloproteinase 7; Oligopeptides; Pancreatic Neoplasms; Prognosis; Proteins; Repressor Proteins; Signal Transduction; Trans-Activators; Wnt Proteins | 2005 |